Froomes P R, Wan A T, Harrison P M, McLean A J
Department of Clinical Pharmacology, Alfred Hospital, Prahran, Victoria, Australia.
Clin Chem. 1988 Feb;34(2):382-4.
This simple, rapid, sensitive, reliable, and economical assay for bismuth in plasma, erythrocytes, and urine is based on atomic absorption spectrophotometry with hydride generation. Acid digestion eliminates the problem of foaming, which hitherto has complicated such assay of bismuth in plasma and erythrocytes. The detection limit of the assay has been improved to 0.1 micrograms/L, as compared with a previously documented limit of 2.5 micrograms/L. Average recovery exceeded 95% in all biological fluids. Economy of use derives from elimination of need for electrodeless discharge lamps and atomic absorption grade borohydride. Determination of basal concentrations of bismuth in clinical samples of body fluids gave reference intervals of 0.1-3.5 micrograms/L for plasma, 0.3-4.6 micrograms/L for urine.
这种用于检测血浆、红细胞和尿液中铋的方法简单、快速、灵敏、可靠且经济,它基于氢化物发生原子吸收分光光度法。酸消解消除了泡沫问题,而在此之前,血浆和红细胞中铋的此类检测因泡沫问题而变得复杂。与之前记录的2.5微克/升的检测限相比,该检测方法的检测限已提高到0.1微克/升。在所有生物体液中,平均回收率超过95%。使用成本的降低源于无需使用无极放电灯和原子吸收级硼氢化钠。对体液临床样本中铋的基础浓度进行测定,得出血浆的参考区间为0.1 - 3.5微克/升,尿液的参考区间为0.3 - 4.6微克/升。